tiprankstipranks
Medtronic Reports Mixed Results in Q3
Market News

Medtronic Reports Mixed Results in Q3

Medtronic (NYSE: MDT), the medical devices company reported Q3 revenues of $7.6 billion, a decline of 3% year-over-year and missing Street estimates by $110 million.

Adjusted earnings came in at $1.30 per diluted share, down by 2% year-over-year and just ahead of analysts’ forecasts of $1.28.

Analysts are cautiously optimistic about MDT stock with a consensus rating of Moderate Buy based on five Buys and 13 Holds, as indicated by the above graphic.

Geoff Martha, Medtronic Chairman, and CEO commented, “Slower than predicted procedure and supply recovery drove revenue below our expectations this quarter. We continue to take decisive actions to improve the overall performance of the company, including streamlining our organizational structure, strengthening our supply chain, driving a performance culture, and strategically allocating capital to support our best growth opportunities with the investments they deserve.”

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles